Is it now time to prepare psychiatry for a psychedelic future?

Nutt, David; Crome, Ilana; Young, Allan H

Abstract

Australia has just rescheduled two drugs controlled under the United Nations Psychotropic Drug Conventions, psilocybin and MDMA, as treatments for treatment-resistant depression and post-traumatic stress disorder respectively. This feature explores the reasons for these developments, the opportunities and challenges they provide to psychiatry communities and how along with health systems these communities might respond to these developments.

Citation

Nutt, D., Crome, I., & Young, A. H. (in press). Is it now time to prepare psychiatry for a psychedelic future?. British Journal of Psychiatry, 1-3. https://doi.org/10.1192/bjp.2024.76

• Journal Article Type: Article
• Acceptance Date: Mar 25, 2024
• Online Publication Date: May 20, 2024
• Deposit Date: Jun 10, 2024
• Journal: The British journal of psychiatry : the journal of mental science
• Print ISSN: 0007-1250
• Publisher: Royal College of Psychiatrists
• Peer Reviewed: Peer Reviewed
• Pages: 1-3
• DOI: https://doi.org/10.1192/bjp.2024.76
• Keywords: psilocybin, depression, PTSD, Psychedelics, MDMA
• Public URL: https://keele-repository.worktribe.com/output/847654
• Publisher URL: https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/is-it-now-time-to-prepare-psychiatry-for-a-psychedelic-future/9A451B79A6B250BEA45BEE2243596FCB#